CHRNB4 (Cholinergic Receptor Nicotinic Beta Subunit 4) encodes the β4 subunit of the nicotinic [acetylcholine](/entities/acetylcholine) receptor (nAChR), a ligand-gated ion channel crucial for cholinergic neurotransmission. The CHRNB4 protein forms part of pentameric neuronal nAChRs that mediate fast synaptic transmission in the central and peripheral nervous systems.
CHRNB4 (Cholinergic Receptor Nicotinic Beta Subunit 4) encodes the β4 subunit of the nicotinic [acetylcholine](/entities/acetylcholine) receptor (nAChR), a ligand-gated ion channel crucial for cholinergic neurotransmission. The CHRNB4 protein forms part of pentameric neuronal nAChRs that mediate fast synaptic transmission in the central and peripheral nervous systems.
Gene Information
Protein Structure and Function
The CHRNB4 protein is a 498-amino acid transmembrane subunit that assembles with other α and β subunits to form functional nAChR channels.[@wu2012] The β4 subunit preferentially assembles with α3, α5, and α7 subunits to form receptors with distinct pharmacological and physiological properties.
These receptors exhibit distinct pharmacological profiles compared to α4β2 and α7 homomeric receptors, with higher sensitivity to certain agonists and different desensitization kinetics.
Role in Neurodegeneration
Alzheimer's Disease
CHRNB4 and other nAChR subunits have been implicated in Alzheimer's disease pathophysiology:
Cholinergic hypothesis: Loss of cholinergic [neurons](/entities/neurons) is a hallmark of AD, and nAChRs are critical targets for therapeutic intervention
Neuroprotection: α4β2 and α7 nAChRs on neurons are neuroprotective against [β-amyloid](/proteins/amyloid-beta) toxicity
Cognitive function: Nicotinic receptors are involved in attention, learning, and memory
Therapeutic targeting: Nicotinic agonists have been explored as AD treatments
Parkinson's Disease
Dopaminergic neuron survival: nAChRs modulate dopamine release and may protect dopaminergic neurons
Levodopa-induced dyskinesias: Nicotinic receptor agonists may reduce dyskinesias in PD patients
Smoking paradox: The inverse relationship between smoking and PD may involve nicotinic receptors
Amyotrophic Lateral Sclerosis (ALS)
Motor neuron function: nAChRs are expressed on motor neurons and may be involved in ALS pathogenesis
Neuroinflammation: Cholinergic signaling modulates neuroinflammation through α7 nAChR-dependent pathways
Nicotinic Agonists in Neurodegeneration
Several nicotinic agonists have been investigated for neurodegenerative diseases:
Clinical Significance
Epilepsy
CHRNB4 mutations have been associated with epilepsy syndromes: